Source explicitly identifies 2025-04-22 as the announcement or milestone date; pin uses this date. Investment period: Five years from April 2025.[1]
Roche announced US$50 billion over five years for pharmaceutical and diagnostics manufacturing and R&D in the United States. The program includes new research sites and new or expanded manufacturing facilities.
1.00